New research boosts hope that a highly anticipated, experimental class of cholesterol drugs can greatly lower the risk for heart attacks, death and other heart-related problems. Studies presented Sunday at a cardiology conference in San Diego suggest that people taking one of these drugs had half the risk of dying or suffering a heart problem compared to others who were given the usual care, typically a statin drug such as Lipitor or Zocor.